Title:
LONG-ACTING COMPOUND
Document Type and Number:
WIPO Patent Application WO/2020/237749
Kind Code:
A1
Abstract:
Provided is a compound having a long-acting therapeutic effect. The compound can be used to prepare an antidepressant drug and drugs for anesthesia, analgesia, improvement of cognitive function, lung protection, amyotrophic lateral sclerosis or complex regional pain syndrome.
More Like This:
JP2002084990 | USE OF α-KETOENAMINE DERIVATIVE AS INGREDIENT |
JP2003513117 | [Title of Invention] Catalyst for Polymerization of Olefin |
WO/2005/099688 | CYCLIC COMPOUNDS |
Inventors:
ZHOU QIANG (US)
YE TAO (CN)
LI SHU PENG (CA)
YE TAO (CN)
LI SHU PENG (CA)
Application Number:
PCT/CN2019/091697
Publication Date:
December 03, 2020
Filing Date:
June 18, 2019
Export Citation:
Assignee:
UNIV PEKING SHENZHEN GRADUATE SCHOOL (CN)
International Classes:
C07C225/20; A61K31/135; A61K31/27; A61P11/00; A61P21/00; A61P23/00; A61P25/04; A61P25/24; A61P25/28; A61P29/00; C07C271/24
Domestic Patent References:
WO2019077332A1 | 2019-04-25 | |||
WO2018104729A1 | 2018-06-14 |
Foreign References:
CN110343050A | 2019-10-18 | |||
CN110540509A | 2019-12-06 | |||
CN110538169A | 2019-12-06 | |||
CN110540510A | 2019-12-06 | |||
CN104395283A | 2015-03-04 |
Attorney, Agent or Firm:
SHENZHEN J & Q INTELLECTUAL PROPERTY CO., LTD. (CN)
Download PDF: